Follow
Chiara Urbinati
Chiara Urbinati
Unknown affiliation
Verified email at unibs.it
Title
Cited by
Cited by
Year
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine
S Mitola, M Belleri, C Urbinati, D Coltrini, B Sparatore, M Pedrazzi, ...
The Journal of Immunology 176 (1), 12-15, 2006
3002006
Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane
D Ribatti, C Urbinati, B Nico, M Rusnati, L Roncali, M Presta
Developmental biology 170 (1), 39-49, 1995
1951995
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use
P Chiodelli, A Bugatti, C Urbinati, M Rusnati
Molecules 20 (4), 6342-6388, 2015
1552015
The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonists
M Rusnati, G Tulipano, C Urbinati, E Tanghetti, R Giuliani, M Giacca, ...
Journal of Biological Chemistry 273 (26), 16027-16037, 1998
1551998
Cutting edge: proangiogenic properties of alternatively activated dendritic cells
E Riboldi, T Musso, E Moroni, C Urbinati, S Bernasconi, M Rusnati, ...
The Journal of Immunology 175 (5), 2788-2792, 2005
1522005
Cell membrane GM1 ganglioside is a functional coreceptor for fibroblast growth factor 2
M Rusnati, C Urbinati, E Tanghetti, P Dell'Era, H Lortat-Jacob, M Presta
Proceedings of the National Academy of Sciences 99 (7), 4367-4372, 2002
1362002
Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: role of the low affinity heparin‐like bFGF receptors
M Rusnati, C Urbinati, M Presta
Journal of cellular physiology 154 (1), 152-161, 1993
1171993
Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives
D Leali, M Belleri, C Urbinati, D Coltrini, P Oreste, G Zoppetti, D Ribatti, ...
Journal of Biological Chemistry 276 (41), 37900-37908, 2001
1122001
Pentosan polysulfate as an inhibitor of extracellular HIV-1 Tat
M Rusnati, C Urbinati, A Caputo, L Possati, H Lortat-Jacob, M Giacca, ...
Journal of Biological Chemistry 276 (25), 22420-22425, 2001
1002001
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts
E Tanghetti, R Ria, P Dell'Era, C Urbinati, M Rusnati, MG Ennas, M Presta
Oncogene 21 (24), 3889-3897, 2002
872002
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures
M Rusnati, E Tanghetti, C Urbinati, G Tulipano, S Marchesini, M Ziche, ...
Molecular Biology of the Cell 10 (2), 313-327, 1999
811999
Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain
B Margosio, M Rusnati, K Bonezzi, AC Blue-leaf, DS Annis, C Urbinati, ...
The international journal of biochemistry & cell biology 40 (4), 700-709, 2008
782008
Interaction of high‐molecular‐weight basic fibroblast growth factor with endothelium: Biological activity and intracellular fate of human recombinant Mr 24,000 bFGF
A Gualandris, C Urbinati, M Rusnati, M Ziche, M Presta
Journal of cellular physiology 161 (1), 149-159, 1994
781994
The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms
G Paiardi, S Richter, P Oreste, C Urbinati, M Rusnati, RC Wade
Journal of Biological Chemistry 298 (2), 2022
642022
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV‐1 Tat protein antagonists
C Urbinati, A Bugatti, P Oreste, G Zoppetti, J Waltenberger, S Mitola, ...
FEBS letters 568 (1-3), 171-177, 2004
622004
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteins
A Bugatti, C Urbinati, C Ravelli, E De Clercq, S Liekens, M Rusnati
Antimicrobial agents and chemotherapy 51 (7), 2337-2345, 2007
602007
A distinct basic fibroblast growth factor (FGF-2)/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells.
M Rusnati, P Dell'Era, C Urbinati, E Tanghetti, ML Massardi, Y Nagamine, ...
Molecular biology of the cell 7 (3), 369-381, 1996
601996
Integrin αVβ3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo
C Urbinati, S Mitola, E Tanghetti, C Kumar, J Waltenberger, D Ribatti, ...
Arteriosclerosis, thrombosis, and vascular biology 25 (11), 2315-2320, 2005
572005
Expression of basic fibroblast growth factor and its receptors in human fetal microglia cells
M Presta, C Urbinati, P Dell'Era, GM Lauro, V Sogos, L Balaci, MG Ennas, ...
International journal of developmental neuroscience 13 (1), 29-39, 1995
571995
αvβ3-integrin-dependent activation of focal adhesion kinase mediates NF-κB activation and motogenic activity by HIV-1 Tat in endothelial cells
C Urbinati, A Bugatti, M Giacca, D Schlaepfer, M Presta, M Rusnati
Journal of cell science 118 (17), 3949-3958, 2005
562005
The system can't perform the operation now. Try again later.
Articles 1–20